Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: SAForm
2009
PHARMAC documents that matched your search:
SA0973 - Gabapentin (Neurontin) - no further approvals
(1 page, 7 KB)
2009/10/21
SA0973 SPECIAL AUTHORITY FOR SUBSIDY Notes: Subsidy for patients pre-approved by PHARMAC on 1 August 2009. Approvals valid without further renewal unless notified. No new approvals will be granted from 1 August 2009. PHARMAC PO Box 10-254 Wellington Phone: 04…
SA0948 – Alendronate Tab 70 mg - with or without Cholecalciferol
(2 pages, 7 KB)
2009/09/01
Special Authority for Subsidy
SA0976 - Dasatinib for treatment of Chronic Myeloid Leukaemia (CML)
(2 pages, 17 KB)
2009/08/03
CHRONIC MYELOID LEUKAEMIA TREATMENT APPLICATION FORM FOR IMATINIB/DASATINIB Please send applications and prescriptions to: The CML Co-ordinator PHARMAC P O Box 10254 Wellington Phone: 04 460 4990 Facsimile: 04 916 7571 Email: mary.chesterfield@pharmac.govt.nz Patient Details (Acceptable to attach hospital sticker)…
1. Guidelines for Pulmonary Arterial Hypertension (PAH) Therapy Special Authority applications
(5 pages, 148 KB)
2009/06/08
ELIGIBILITY CRITERIA FOR INITIATION OF PULMONARY ARTERIAL HYPERTENSION THERAPY These guidelines are intended to assist relevant practitioners in gauging which patients are likely to be approved for pulmonary arterial hypertension treatments. In view of the complexity of pulmonary arterial hypertension…
2. Adults Initial PAH application form
(9 pages, 166 KB)
2009/06/08
Initial Application for Funding of Pulmonary Arterial Hypertension Treatments for Adults (and children aged over 10 years) Please send applications to: PAH Panel Coordinator PHARMAC P O Box 10-254 WELLINGTON Phone: 04 9167 512 Facsimile: 04 460 4858 Email: PAH@pharmac.govt.nz…
